Neoplasm
Not recruitingStudy on the Safety and Effectiveness of TNG462 for Patients with Advanced or Metastatic Solid Tumors with MTAP Deletion
Study on the Safety and Effectiveness of TNG462 for Patients with Advanced or Metastatic Solid Tumors with MTAP Deletion
- Disease:Neoplasm
- Substances:N-(6-AMINO-5-ETHYLPYRIDIN-3-YL)-2-((2R,5S)-5-METHYL-2-(2-(1-METHYLPIPERIDIN-4-YL)BENZO[D]THIAZOL-5-YL)PIPERIDIN-1-YL)-2-OXOACETAMIDE
France- Participants:18–64 years · 65+ years
- Substances:N-(6-AMINO-5-ETHYLPYRIDIN-3-YL)-2-((2R,5S)-5-METHYL-2-(2-(1-METHYLPIPERIDIN-4-YL)BENZO[D]THIAZOL-5-YL)PIPERIDIN-1-YL)-2-OXOACETAMIDE












